asenapine has been researched along with Weight Gain in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellino, S; Bozzatello, P; Rocca, P; Uscinska, M | 1 |
| Montes, JM; Vieta, E | 1 |
| Beauchemin, C; Beillat, M; Gilbert, D; Lachaine, J; Mathurin, K | 1 |
| Cazorla, P; Kemp, DE; Landbloom, RP; Mackle, M; Snow-Adami, L; Szegedi, A; Zhao, J | 1 |
| Azorin, JM; Chang, S; Guiraud-Diawara, A; Hansen, K; Marre, C; Rinciog, C; Sawyer, L | 1 |
| El-Mallakh, RS; Worthington, MA | 1 |
| Hundt, C; Kelly, L; Landbloom, R; Mackle, M; Mathews, M; McIntyre, RS; Snow-Adami, L; Wu, X | 1 |
| Kane, JM; Mackle, M; Panagides, J; Snow-Adami, L; Szegedi, A; Zhao, J | 1 |
| Franklin, DL; Kirsten, J; Maguire, GA | 1 |
| Potkin, SG | 1 |
| Emsley, R; Naber, D; Panagides, J; Schoemaker, J; Stet, L; Vrijland, P | 1 |
| Correll, CU; De Hert, M; Detraux, J; Sweers, K; van Winkel, R; Yu, W | 1 |
| Bossini, L; Casamassima, F; Cuomo, A; Fagiolini, A; Forgione, RN; Goracci, A; Maccari, M; Morana, B; Pellegrini, F | 1 |
6 review(s) available for asenapine and Weight Gain
| Article | Year |
|---|---|
A Review of Asenapine in the Treatment of Bipolar Disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzocycloheptenes; Dizziness; Heterocyclic Compounds, 4 or More Rings; Humans; Olanzapine; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; Weight Gain | 2018 |
Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cholesterol, LDL; Controlled Clinical Trials as Topic; Dibenzocycloheptenes; Female; Hematologic Tests; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Treatment Outcome; Triglycerides; Weight Gain | 2014 |
Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Controlled Clinical Trials as Topic; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Schizophrenia; Weight Gain | 2010 |
Asenapine: a clinical overview.
Topics: Antipsychotic Agents; Blood Glucose; Dibenzocycloheptenes; Dyslipidemias; Heterocyclic Compounds, 4 or More Rings; Humans; Schizophrenia; Treatment Outcome; Weight Gain | 2011 |
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Isoindoles; Isoxazoles; Lipid Metabolism; Lurasidone Hydrochloride; Paliperidone Palmitate; Piperidines; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Weight Gain | 2012 |
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
Topics: Administration, Sublingual; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Clinical Trials as Topic; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Metabolic Clearance Rate; Weight Gain | 2013 |
4 trial(s) available for asenapine and Weight Gain
| Article | Year |
|---|---|
Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Borderline Personality Disorder; Dibenzocycloheptenes; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Hypesthesia; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Weight Gain; Young Adult | 2017 |
Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dibenzocycloheptenes; Disease Progression; Disorders of Excessive Somnolence; Dizziness; Double-Blind Method; Dysgeusia; Europe; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Hypesthesia; Least-Squares Analysis; Male; Mouth Diseases; Olanzapine; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Gain | 2017 |
A randomized placebo-controlled trial of asenapine for the prevention of relapse of schizophrenia after long-term treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Anxiety; Dibenzocycloheptenes; Double-Blind Method; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Secondary Prevention; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Gain; Young Adult | 2011 |
Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comparative Effectiveness Research; Diagnostic and Statistical Manual of Mental Disorders; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Drug Monitoring; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Longitudinal Studies; Male; Middle Aged; Olanzapine; Pharmacovigilance; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Time; Treatment Outcome; Weight Gain | 2012 |
4 other study(ies) available for asenapine and Weight Gain
| Article | Year |
|---|---|
Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Canada; Cost-Benefit Analysis; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Olanzapine; Quality-Adjusted Life Years; Weight Gain | 2014 |
Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Cost-Benefit Analysis; Dibenzocycloheptenes; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Markov Chains; Models, Economic; Olanzapine; Quality-Adjusted Life Years; State Medicine; United Kingdom; Weight Gain | 2014 |
A naturalistic retrospective review of weight gain in bipolar patients treated with second generation antipsychotics.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Body Weight; Dibenzocycloheptenes; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Middle Aged; Retrospective Studies; Weight Gain | 2015 |
Asenapine for the treatment of stuttering: an analysis of three cases.
Topics: Antipsychotic Agents; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Middle Aged; Speech; Stuttering; Treatment Outcome; Weight Gain; Young Adult | 2011 |